Literature DB >> 2812531

Calibration of [14C]plastic standards for quantitative autoradiography of [125I]labeled ligands with Amersham Hyperfilm beta-max.

D G Baskin1, T H Wimpy.   

Abstract

The densitometric response of Hyperfilm beta-max (HFBM) to [14C]plastic standards was calibrated to tissue-equivalent concentrations of [125I]. Plastic sections with standard concentrations of [125I] and [14C] were apposed to HFBM for 1, 3, 5, and 9 days, with liver and muscle slices (20 microns thick) labeled with [125I]insulin. The relative optical densities (ROD = log 10 [1/gray level x 256(-1)] produced by [125I]- and [14C]plastic standards were converted to equivalent tissue [125I] concentrations (dpm/mm2). The response of HFBM to the [125I]- and [14C]plastic standards was similar (P less than 0.001). Standard curves of tissue [125I] (dpm/mm2) vs plastic [14C] (microCi/g) concentrations fit second order polynomials (r2 = 0.995-0.999). The results show that [14C]plastic standards are valid for measuring [125I] radioactivity in tissue slices by autoradiography with HFBM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812531     DOI: 10.1016/0304-3940(89)90350-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Early locus coeruleus lesions increase the density of beta-adrenergic receptors in the main olfactory bulb of rats.

Authors:  C C Woo; D A Wilson; R M Sullivan; M Leon
Journal:  Int J Dev Neurosci       Date:  1996-11       Impact factor: 2.457

2.  The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.

Authors:  Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Sean R Donohou; Victor W Pike; Christer Halldin; Domokos Máthé; László Csiba; Balázs Gulyás
Journal:  Brain Res Bull       Date:  2012-03-07       Impact factor: 4.077

3.  [¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease.

Authors:  Szabolcs Farkas; Katalin Nagy; Miklós Palkovits; Gábor G Kovács; Zhisheng Jia; Sean Donohue; Vic Pike; Christer Halldin; Domokos Máthé; Tibor Harkany; Balázs Gulyás; László Csiba
Journal:  Neurochem Int       Date:  2011-12-28       Impact factor: 3.921

4.  Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting.

Authors:  Meike Körner; Beatrice Waser; Agnes Schonbrunn; Aurel Perren; Jean Claude Reubi
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

5.  Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.

Authors:  Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

6.  Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

Authors:  Eyup Akgün; Meike Körner; Fan Gao; Kaleeckal G Harikumar; Beatrice Waser; Jean Claude Reubi; Philip S Portoghese; Laurence J Miller
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

7.  CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.

Authors:  Meike Körner; Beatrice Waser; Jean Claude Reubi; Laurence J Miller
Journal:  J Cell Mol Med       Date:  2009-07-20       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.